Search results

Technologies 1

• CogniXense for Rare Disease Drug Discovery
  Unravel Biosciences has licensed a Wyss drug discovery platform technology to identify and create drugs to treat complex central nervous system disorders, starting with Rett syndrome.

News 11

View all

• Press Release
  
  DARPA-ABC program supports Wyss Institute-led collaboration toward deeper understanding of anesthesia and safe drugs enabling anesthesia without the need for extensive monitoring
  January 15, 2025
• Press Release
  
  Scientists build tiny biological robots from human cells
  November 30, 2023
• Translation News
  
  Unravel Biosciences licenses Wyss Institute platform technology from Harvard and Tufts University to decode, model, and treat complex diseases
  September 27, 2022

Multimedia 3

• 

  Video/Animation
  20-ish Questions with Michael Levin
  20-ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Michael Levin, an Associate Faculty member of the Wyss Institute, as well as the Director of the Allen Discovery Center at Tufts and Tufts Center for Regenerative and...

• 

  Video/Animation
  Frontier Science #10: Bioelectrics w/ Michael Levin
  Michael Levin, a Wyss Associate Faculty member and a Distinguished Professor in the Biology department at Tufts, holds the Vannevar Bush endowed Chair and serves as director of the Allen Discovery Center at Tufts and the Tufts Center for Regenerative and Developmental Biology. Recent honors include the Scientist of Vision award and the Distinguished Scholar...

• 

  Video/Animation
  Humans of the Wyss – Faculty Edition with Mike Levin
  Our interview series, “Humans of the Wyss – Faculty Edition,” features Wyss Institute faculty members discussing how they think about their work, the influences that helped shape them as scientists, and their collaborations at the Wyss Institute and beyond. In the second edition of the series, Benjamin Boettner, Wyss Institute Communications team member, talks to...